Several recent studies have reported that FRLs affect the development and progression of solid tumors by serving as competing endogenous RNAs, such as OIP5-AS1 in prostate cancer and MT1DP in non-small-cell lung cancer [41, 42]. The gene discussed is MT1DP; the disease is prostate carcinoma.